This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
On December 29, 2024, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy hosted Session 12 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative, focusing on Complaints and Product Recall. The session provided clarity on the guidelines and cleared the queries of the pharma professionals.
FDA-2024-N-3945 ] announcing the publication of a draft strategy document, for public comment, outlining specific actions FDA plans to take to facilitate the use of innovative manufacturing technologies. It was at this workshop that the agency committed to issuing a draft strategy document, for public comment.
It’s like a bridge connecting the intricate world of medical science to everyday healthcare communication. As a specialized field, medical writing encompasses the creation of various documents, from regulatory submission documents to medical journal articles, that convey critical medical knowledge to diverse audiences.
The updated guidance includes information on the general requirements for the content of FDA-regulated promotional communications about reference or biosimilar products and provides some examples to illustrate the FDA’s current recommendations for addressing reference, biosimilar, and interchangeable biosimilar products in product promotion.
FOPE and Pharma State Academy recently hosted, third session of their PULSE series on August 11, 2024, spotlighting “Quality Risk Management (QRM)” with a special focus on the Revised Schedule M. The panel also discussed the differences between ICH Q9 and the Revised Schedule M, and the importance of meticulous documentation.
Below we highlight FDA’s views about best practices for BIMO inspection communications, handling requests for records, and inspection preparation and follow-up as outlined in the draft guidance. Communication Best Practices During a BIMO Inspection Provide timely and accurate responses to information requests.
Other members include health-related associations and nonprofit organizations including the provider, research, and family caregiver communities; and businesses and organizations representing biopharmaceuticals, devices, diagnostics, generics, and payers.
The government previously announced £150 million (around $200 million) to help drive digitisation in social care, and a target of 80% of social care providers to have digital social care records by March 2024.
Recognizing both the potential benefits and challenges of the MPPP rollout, the NHC views the introduction of these documents as crucial for educating beneficiaries on their options, easing transitions, and possibly lessening the financial impact of prescription costs.
With 2024 rapidly approaching, there comes the question of New Year’s Resolutions. Patient Communication Some call it creating “happy patients,” others want to improve “patient experience,” and yet others mention “patient satisfaction.” To simplify our EHR and make documentation easier and quicker.
The stress experienced by community pharmacists compared to those in other settings is well-documented and has been a longstanding issue. A cultural shift within the profession is also needed, encouraging open communication and prioritizing self-care to create a supportive environment for pharmacists.
This shift highlights the significance of effective communication, teamwork, and adaptability. Despite the challenge of quantifying these skills, their influence on a student’s ability to cultivate professional relationships, effectively communicate, and collaborate in a team cannot be overstated. teacher), entertainment (ex.
The primary vehicle for FDA to request cybersecurity information in premarket submissions has been guidance documents. The technological characteristics in this context may cover a wide range of device functions, for instance, monitoring features, stimulation parameters, and communications with healthcare providers.
BCPS, BCIDP Article posted 13 December 2024 If you cannot measure it, you cannot determine if you have changedit. Along this line of thought, I have also learned to be gentle with how I communicate my lack of confidence in data that is shared with me. Authored by: Timothy P. Gauthier, Pharm.D.,
A Reminder of NHC Benefits February 5, 2024 By: Bob Scott, Director, Member Services The National Health Council (NHC) brings diverse organizations together to forge consensus, drive patient-centered health policy, and provide a united voice for the more than 160 million people with chronic diseases and disabilities and their family caregivers.
On June 12, 2024, Food and Drug Administration (FDA) issued exemptions for certain dispensers and in limited scenarios, their trading partners, from certain requirements of section 582 under the Food Drug and Cosmetic Act (FD&C Act) until November 27, 2026. So, what does this all mean for DSCSA implementation for the dispenser community?
January 22, 2024 By: Annlouise Assaf – Sr. However, content must be presented in a clear and easily accessible way using plain language that is easy to understand and effectively communicated. There are customizable health literacy checks content developers can include when reviewing their documents. Patient Educ Couns.
The document provides minor updates on procedures, incorporating recent developments and experiences in how FDA interacts with industry. Draft Guidance Finally, as part of MDUFA V , FDA has committed to issuing an updated draft of this Q-Sub guidance, by March 31, 2024.
Key Points of Support Conciseness and Focus of Key Information The NHC supports the FDA’s emphasis on beginning the informed consent document with concise, focused presentations of key information. Clarity in communication is not just about convenience; it is a fundamental aspect of ethical medical practice and research.
BCPS, BCIDP Article Posted October 2024, First Released in the June 2024 IDstewardship Newsletter Tip 1: Start by picking an article type and journal The article type (e.g., brief report, concise communication) will provide structure guidance (number of words, figures/tables, references allowed). Gauthier, Pharm.D.,
Consensus Framework Makes International Debut October 3, 2024 By: Joy D. Third, it promotes appropriate transparency and accountability in our individual and collaborative efforts, encouraging open communication to enhance accountability and reduce conflicts of interest. Consensus Framework document here. health system.
It is vital that communication, both for beneficiaries and for health care providers and pharmacists, adhere to these principles. The NHC supports the development and use of processes and tools that enhance beneficiary experience, making interactions with the MPPP smoother and more intuitive for all beneficiaries.
It is vital that communication, both for beneficiaries and for health care providers and pharmacists, adhere to these principles. The NHC supports the development and use of processes and tools that enhance beneficiary experience, making interactions with the MPPP smoother and more intuitive for all beneficiaries.
Furthermore, it is crucial to understand how patients perceive the communication and support they receive from health care providers regarding the management of their medications. Additionally, the NHC recommends including questions that explore how these access challenges were communicated and managed by health care providers.
As noted in our previous communications, while the NHC would prefer a more traditional Notice and Comment rulemaking opportunity that would ensure the Agency directly responds to stakeholder feedback, we welcome this opportunity to express our reactions to CMS’ thinking on the negotiation program.
Instrument calibration procedure for pharmaceutical industry Pharmaceuticals quality assurance & validation procedures GMPSOP %title% Last Updated on March 20, 2024 Prev PREVIOUS POST Have you ever wondered if the scales at the grocery checkout show the right amount? Additional documents included each month. Subscribe f.
Engaging these communities in the policy development process ensures that their voices are heard and that their unique perspectives are incorporated into policy decisions. This includes obtaining informed consent, anonymizing data, and clearly communicating how the data will be used and protected.
Failure to Reconcile (FTR) Process: The NHC views the proposed changes to the FTR process positively as safeguarding consumers’ health coverage access, particularly for those with chronic conditions, by enhancing education, aligning with consumer protection principles, and ensuring clarity and accessibility in communication strategies.
An important accompanying document for Joint Commission standards are Critical Access Hospital Accreditation Survey Activity Guide, for which the January 2023 guide can be found here. The latest antimicrobial stewardship regulations from The Joint Commission went into effect in January 2023.
NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials (PDF) September 26, 2024 The Honorable Robert M. As part of this ongoing commitment, the NHC convened a virtual meeting on August 5, 2024, to discuss this draft guidance. Califf, MD Commissioner U.S.
We appreciate CMS’ efforts to gather public input before finalizing the 73 new HCPCS codes made effective on April 1, 2024, and the 127 new codes made effective on July 1, 2024. amazonaws.com/s3fs-public/documents/Update_HHS_Disparities_Dept-FY2020.pdf Implementation Science Communications, 11(1) , 165. Auerbach, J.,
The continuation of audio-only communication options remains essential. These codes facilitate proper documentation and reimbursement, ensuring that health care providers are fairly compensated for the critical services they offer. 18530 (2024) (to be codified at 44 C.F.R. BMC Health Services Research, 22(1) :438. 1, 2, and 3).
The deadline for the Draft Guidance was December 29, 2023, so the draft, issued on June 26, 2024, is about 6 months late under FDORA’s mandate. Procedures for Submitting the DAP Sponsors should describe the DAP clearly and concisely, with limited cross-referencing to previously submitted documents. Some unanswered questions remain.
GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019 [i]. Consent documents often describe technical medical conditions and regulatory bodies are increasing pressure on sponsors to ensure that patient-facing information can be easily understood by patients.
According to the legal documents , the plaintiffs accused the companies of “violating federal antitrust laws, alleging “per se” and “rule of reason” violations”. Gilenya is an oral medication for multiple sclerosis. Fighting Entresto generics. Please check your email to download the Report.
AI algorithms can analyze scores of documents quickly and retrieve only those that threaten the validity of patents, enabling organizations to prioritize consolidating their IP portfolios by locating and rectifying weaknesses. AI in Patent Drafting and Filing AI is also streamlining the patent drafting and filing process.
The NHC also emphasizes the importance of clear communication and transition planning to minimize disruptions. The NHC encourages CMS to provide regular updates on guidance documents and implementation progress to keep stakeholders informed and responsive to emerging challenges. Use of Medicines in the U.S.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content